Kenan Onel

7.0k total citations · 1 hit paper
78 papers, 3.1k citations indexed

About

Kenan Onel is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Kenan Onel has authored 78 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 21 papers in Hematology and 21 papers in Cancer Research. Recurrent topics in Kenan Onel's work include Cancer Genomics and Diagnostics (15 papers), Acute Lymphoblastic Leukemia research (14 papers) and DNA Repair Mechanisms (11 papers). Kenan Onel is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Acute Lymphoblastic Leukemia research (14 papers) and DNA Repair Mechanisms (11 papers). Kenan Onel collaborates with scholars based in United States, United Kingdom and Canada. Kenan Onel's co-authors include Carlos Cordon‐Cardo, Louise C. Strong, Gareth L. Bond, Elisabeth E. Bond, Jill Bargonetti, Arnold J. Levine, Peter Wuerl, Stuart Lutzker, Nicoleta C. Arva and Shih-Jen Hwang and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Kenan Onel

74 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans

2004 1.0k citations Gareth L. Bond, Wenwei Hu et al. Cell profile →

Peers

Countries citing papers authored by Kenan Onel

Since Specialization

Citations

This map shows the geographic impact of Kenan Onel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenan Onel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenan Onel more than expected).

Fields of papers citing papers by Kenan Onel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenan Onel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenan Onel. The network helps show where Kenan Onel may publish in the future.

Co-authorship network of co-authors of Kenan Onel

This figure shows the co-authorship network connecting the top 25 collaborators of Kenan Onel. A scholar is included among the top collaborators of Kenan Onel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenan Onel. Kenan Onel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Germline POT1 Variants in a Pan-Cancer Cohort 2025 ·JCO Precision Oncology ·Pamela Brock, M. N. Webster, Sandya Liyanarachchi, Lindsey Byrne, Dale J. Hedges, Pat Gulhati, J. Kevin Hicks, Carlos H.F. Chan, Kenan Onel, (unknown), (unknown), (unknown), Juvianee Estrada‐Veras, Bodour Salhia, Lisen Axell, Laura L. Holman, Mohamed H. Abdel‐Rahman, Matthew D. Ringel	0
2	The Diagnostic Yield of Panel Versus Exome Sequencing to Identify Hereditary Cancer Disorders in Pediatric Cancer 2025 ·Journal of Pediatric Hematology/Oncology ·(unknown), (unknown), Dorota Gruber, Kenan Onel, Carolyn Fein Levy	0
3	Pancreatic adenocarcinoma in a patient with a germline RB1 pathogenic variant 2025 ·Familial Cancer ·(unknown), Christos Fountzilas, (unknown), Emily Schultz, (unknown), Erik S. Knudsen, Agnieszka K. Witkiewicz, Kenan Onel	0
4	FaMMily Affairs: Dissecting inherited contributions to multiple myeloma risk 2024 ·Seminars in Hematology ·(unknown), (unknown), Julie Gold, (unknown), Alessandro Laganà, Kenan Onel, Sundar Jagannath, Samir Parekh, Santiago Thibaud	1
5	Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study 2021 ·Cells ·Nazlisadat Seyed Khoei, Robert Carreras‐Torres, Neil Murphy, Marc J. Gunter, Paul Brennan, Karl Smith-Byrne, Daniela Mariosa, James McKay, Tracy A. O’Mara, Ruth F. Jarrett, Henrik Hjalgrim, Karin E. Smedby, Wendy Cozen, Kenan Onel, Arjan Diepstra, Karl‐Heinz Wagner, Heinz Freisling	22
6	Functional Common and Rare ERBB2 Germline Variants Cooperate in Familial and Sporadic Cancer Susceptibility 2021 ·Cancer Prevention Research ·Riyue Bao, (unknown), Mark M. Sasaki, Myvizhi Esai Selvan, Alyna Katti, (unknown), Lei Huang, Andrew D. Skol, Cinzia Lavarino, S.P. Hector, Robert J. Klein, Zeynep H. Gümüş, (unknown), Kenan Onel	2
7	Precision oncology: lessons learned and challenges for the future 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), David Tegay, Kenan Onel	0
8	<p>Precision oncology: lessons learned and challenges for the future</p> 2019 ·Cancer Management and Research ·Hsih‐Te Yang, Ronak Shah, David Tegay, Kenan Onel	9
9	Comparing ethnicity-based and expanded carrier screening methods at a single fertility center reveals significant differences in carrier rates and carrier couple rates 2018 ·Genetics in Medicine ·Alexandra Peyser, (unknown), Christine Mullin, Sara L. Bristow, (unknown), Kenan Onel, Avner Hershlag	28
10	Integrated Genomic Analysis Suggests MLL3 Is a Novel Candidate Susceptibility Gene for Familial Nasopharyngeal Carcinoma 2015 ·Cancer Epidemiology Biomarkers & Prevention ·Mark M. Sasaki, Andrew D. Skol, Riyue Bao, Lindsay Rhodes, Rachelle Chambers, Everett E. Vokes, Ezra E.W. Cohen, Kenan Onel	11
11	Sociodemographic Disparities in Differentiated Thyroid Cancer Survival Among Adolescents and Young Adults in California 2015 ·Thyroid ·Theresa H.M. Keegan, Raymon H. Grogan, Helen Parsons, (unknown), Michael G. White, Kenan Onel, Pamela L. Horn‐Ross	54
12	Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation 2015 ·Biology of Blood and Marrow Transplantation ·Theresa Hahn, Lara E. Sucheston‐Campbell, Leah Preus, Xiaochun Zhu, John A. Hansen, Paul J. Martin, Li Yan, Song Liu, Stephen R. Spellman, David Tritchler, Alyssa Clay‐Gilmour, Kenan Onel, Marcelo C. Pasquini, Philip L. McCarthy	16
13	Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia 2015 ·BMC Bioinformatics ·Xinan Yang, Meiyi Li, Bin Wang, Wanqi Zhu, (unknown), Kenan Onel, (unknown), Jianjun Chen, Luonan Chen, John M. Cunningham	8
14	The APC tumor suppressor is required for epithelial cell polarization and three-dimensional morphogenesis 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), Kathleen H. Goss, Frank Yang, (unknown), Imge Hulur, Kenan Onel, Jenifer R. Prosperi	20
15	Identification and Utilization of Donor and Recipient Genetic Variants to Predict Survival After HCT: Are We Ready for Primetime? 2015 ·Current Hematologic Malignancy Reports ·Lara E. Sucheston‐Campbell, Alyssa Clay‐Gilmour, Philip L. McCarthy, Qianqian Zhu, Leah Preus, Marcelo C. Pasquini, Kenan Onel, Theresa Hahn	5
16	Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes 2012 ·Leukemia & lymphoma ·Jane E. Churpek, (unknown), (unknown), Kenan Onel, Olufunmilayo I. Olopade, April Sorrell, Carolyn Owen, Alison A. Bertuch, Lucy A. Godley	61
17	Anti–tumor necrosis factor therapy and cancer risk in patients with autoimmune disorders 2010 ·Arthritis Care & Research ·Karen Onel, Kenan Onel	14
18	Genetic predictors of long‐term toxicities after radiation therapy for breast cancer 2007 ·International Journal of Cancer ·(unknown), (unknown), Silke Kropp, Irmgard Helmbold, Peter Schmezer, D. von Fournier, W. Haase, M.-L. Sautter-Bihl, Frederik Wenz, Kenan Onel, Christine B. Ambrosone	42
19	MDM2 and Prognosis 2004 ·Molecular Cancer Research ·Kenan Onel, Carlos Cordon‐Cardo	158
20	A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans breakdown → 2004 ·Cell ·Gareth L. Bond, Wenwei Hu, Elisabeth E. Bond, Harlan Robins, Stuart Lutzker, Nicoleta C. Arva, Jill Bargonetti, Frank Bartel, Helge Täubert, Peter Wuerl, Kenan Onel, Linwah Yip, Shih-Jen Hwang, Louise C. Strong, Guillermina Lozano, Arnold J. Levine	1026

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact